STAGE III PROSTATE CANCER AJCC V8
Clinical trials for STAGE III PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Testosterone therapy may improve life for men with prostate cancer – without causing harm
Disease control TerminatedThis study looks at whether testosterone replacement therapy (TRT) is safe and beneficial for men with low-risk prostate cancer who are on active surveillance (watchful waiting). Many doctors avoid TRT in these patients due to fears it might make cancer grow, but this trial aims …
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE4 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
Promising prostate cancer combo study pulled before it started
Disease control TerminatedThis study aimed to see if adding the immunotherapy drug pembrolizumab to standard hormone therapy and radiation could improve outcomes for men with high-risk prostate cancer that hasn't spread. It was designed for adults with newly diagnosed, localized disease. However, the stud…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 01, 2026 15:40 UTC
-
Immunotherapy plus chemo shows promise for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help people with rare, aggressive small cell or neuroendocrine cancers of the bladder or prostate. About 15 adults whose cancer has spread will receive the combination. T…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC